Citations

Clear

42 citation(s) found for "John, Thomas".

Optimal Selection of the Effective Echo Time ( TE eff ) for T2 ‐Weighted Fast
Kim, Dahan , Pabi, Ronard, Borisch, Eric A. , Froemming, Adam T. , Grimm, Roger C., Hassanzadeh, Sara, Kawashima, Akira , Takahashi, Naoki , Thomas, John V. , Riederer, Stephen J. , Kido, Ayumu, Takahashi, Naoki , Riederer, Stephen J , Kawashima, Akira , Kido, Ayumu

Mayo Clinic

Journal of Magnetic Resonance Imaging | April 24, 2026 | Volume: 64 | Issue: 3 | Pages: 616-628

10.1002/jmri.70351 | PMID 42026845 Get It

ABSTRACT Background Clinical T 2 ‐weighted (T2W) MRI of prostate cancer (PCa) usually implements a 2D fast‐spin‐echo (FSE) sequence, but understanding the echo‐time‐dependent contrast behavior is not straightforward due to the complicated FSE signal evolution. Consequently, consensus‐based recommendations on the optimal effective echo time (TE eff ) to maximize contrast are lacking. Purpose To investigate the effect of TE eff on PCa lesion contrast in prostate T2W MRI. Study Type Phantom and in vivo prospective study. Subjects A standard MRI phantom and 53 prostate cancer patients (29 for image evaluation and 24 for quantitative lesion analysis). Field Strength and Sequence Multi‐slice T2W FSE sequence at 3 T acquired at multiple TE eff values. Assessment Three readers (13, 25, and 27 years' experience) evaluated TE eff = 100 ms versus 150 ms on diagnostic quality and reader preference. The effective T 2 relaxation rates ( T 2,eff ) were measured using FSE sequences in the phantom and used to predict the optimal TE eff maximizing T2W contrasts. From multi‐TE eff scans of subjects with suspected PCa, T 2,eff values of PCa lesions and healthy tissue were measured and used to calculate the optimal TE eff maximizing the lesion contrast. In vivo contrast metrics were measured as a function of TE eff . Statistical Tests Wilcoxon test of reader scores, with p < 0.05 defining statistical significance. Results No statistically significant difference was found in diagnostic quality between TE eff = 150 ms and 100 ms images, but all three readers significantly favored TE eff = 150 ms. Phantom experiments demonstrated that TE eff ‐dependent FSE signal progression can be characterized by T 2,eff values typically 40% longer than actual T 2 values, allowing accurate prediction of optimal TE eff within 2%–5%. Applied to PCa imaging, in vivo measurements indicated that effective T 2 relaxation times of the prostate are on average 1.5× longer than published T 2 values. Data Conclusion The benefits of TE eff = 150 ms versus 100 ms in prostate T2W FSE were supported by reader preference, phantom experiments, in vivo measurements, and analytic optimizations. Evidence Level 2. Technical Efficacy 2.
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis
Dabaja, Bouthaina S., Görlich, Dennis , Thomas, Bjorn , Sim, Van , Johnstone, P., Hashmi, Ayesha, Levis, M., Ackerson, Bradley, Hague, Christina J. , Roos, Daniel Edward, Kirova, Y., Fietkau, Rainer, Fang, Penny Q., Ng, A., Bock, Felix, Linde, Philipp , Dunst, Jürgen, Terezakis, Stephanie A, Easwaran, Teresa, Peeken, Jan C. , Wittig, Andrea, Yoon, Hong In , Illidge, Tim , Ricardi, U., Morris, S., Storck, Michael , Hoppe, Richard T, Eich, Hans Theodor, Hoppe, Richard T. , Levis, Mario , Oertel, Michael , Görlich, Dennis , Thomas, Bjorn R , Sim, Van , Levis, Mario , Weil, Christopher R , Bock, Felix , Peeken, Jan C , Yoon, Hong In , Tao, Randa , Binkley, Michael Sargent , Campbell, Belinda A , Elsayad, Khaled , Storck, Michael , Hoppe, Richard T , Hashmi, Ayesha , Weil, Christopher R. , Plastaras, John Peter , Roos, Daniel E. , Fietkau, Rainer , Fang, Penny , Tseng, Yolanda D. , Tao, Randa , Kelsey, Chris R. , Binkley, Michael S. , Eich, Hans Theodor

Mayo Clinic

Blood | March 13, 2026 | Volume: 147 | Issue: 25 | Pages: 3051-3060

10.1182/blood.2025032050 | PMID 41824381 Get It

Abstract Radiotherapy is an established treatment for low-grade primary cutaneous B-cell lymphoma. Recommendations on its use differ internationally, which prompted our group to conduct this analysis. Twenty-two institutions participated in this international study. Patient eligibility required a diagnosis of limited (T1/T2) primary cutaneous marginal zone or follicle center lymphoma treated with radiotherapy between 1995 and 2023. Data were collected retrospectively until February 2024 within the framework of the International Lymphoma Radiation Oncology Group. Overall, 535 patients were analyzed. Predominant locations were the head (40%) and trunk (36%). Radiotherapy had a median dose of 24 Gy in fractions of 2 Gy. Complete responses were observed in 91% at a median time of 3.6 months following radiotherapy. There was no statistically significant difference between treatments ≤4 Gy and &gt;4 Gy for complete or overall response rates (P = .077 and P = .056, respectively). However, there was an inferior duration of local control with ≤4 Gy (5-year local control 73% ± 12% vs 96% ± 2%; P&lt; .001). Radiation dose was the main prognostic factor in the univariate and multivariable Cox analysis; however, higher doses did not translate into an overall survival benefit. Toxicities rarely exceeded grade 2 but were more frequent in the &gt;4 Gy group. Radiotherapy remains an effective treatment option for indolent skin lymphoma with low toxicity. High response rates are observed with low doses of ≤4 Gy. In comparison to conventional doses, these treatments have a shorter duration of local control but a favorable toxicity profile.
MIF-CD74 signaling drives immune modulation in medulloblastoma
Draper, Benjamin, You, Zhen , Thompson, Dean, Guo, Xu, Morcavallo, Alaide , Pino, Diego Chillón, Nery, Carlos Lorenzo Gido, Shrestha, Sumana , Himsworth, Courtney , Delaidelli, A., Morlando, Sonia , Wade, Brandon, Gordon, Freya , Sanchez-Corrales, Yara, Hopkins, Bei, Monteiro, Natalie, Locke, Darren, Liu, Miao , Diaz, Jacob Torrejon, Greenslade, Kevin , Costa, Barbara Martins Da , Barker, Karen, Fletcher, Anya, Custódia, Carlos , Roque, Rafael , Jackson, Thomas, Barfoot, Regan, Castellano, Sergi , Hill, Rebecca M. , Saulnier, Olivier , Jacques, Thomas S, Faria, Claudia C , Ayrault, Olivier , Sorensen, Poul H., Anderson, John, Chesler, Louis, Huang, L Frank, Clifford, Steven C. , Castellano, Sergi , Jacques, Thomas S , Donovan, Laura K , Draper, Benjamin , Thompson, Dean , Bowers, Chantelle E , Delaidelli, Alberto , Remeniuk, Bethany , Sánchez-Corrales, Yara E. , Hopkins, Bei, Torrejon-Diaz, Jacob, Barker, Karen T. , Kwok, Colin , Ogunbiyi, Olumide Kayode , Richardson, Stacey , Jackson, Thomas John , Jacques, Thomas S. , Taylor, Michael D. , Anderson, John, Chesler, Louis , Huang, L Frank

Mayo Clinic

Neuro-Oncology | February 3, 2026 | Volume: 28 | Issue: 5 | Pages: 1316-1334

10.1093/neuonc/noag020 | PMID 41652893 Get It

Abstract Background Relapsed medulloblastoma remains a significant therapeutic challenge as it is near universally fatal. The tumor microenvironment of medulloblastoma plays a critical role in tumor progression, influencing tumor growth, immune evasion, and therapeutic resistance. We hypothesized that defining tumor-immune interactions in diagnostic and relapsed medulloblastoma may uncover mechanisms of immune evasion and identify novel therapeutic targets. Methods We analyzed paired primary and recurrent RNA-sequencing data from 140 medulloblastoma patients to profile immune cell composition and validate spatial relationships within the TME. To identify key tumor-immune interactions, we developed a novel algorithm to detect receptor-ligand pairs using single-cell RNA-sequencing data. These interactions were validated across RNA and proteomic datasets. Their functional significance was empirically demonstrated in newly developed immunocompetent models of recurrent medulloblastoma that closely recapitulate the human disease. Results We observed a shift toward a heightened immunosuppressive TME at relapse. Using our algorithm, we identified biologically significant receptor-ligand interactions, most notably MIF-CD74, constitutively expressed at RNA and protein levels across medulloblastoma subgroups, at diagnosis and relapse. Disrupting MIF-CD74 interactions led to significant alterations in the tumor microenvironment, highlighting its functional significance. Conclusions Our multifaceted approach identified key tumor-immune interactions in medulloblastoma. Among these, MIF-CD74 was validated as a targetable interaction, demonstrating the utility of our integrative approach for identifying novel therapeutic targets across multiple tumor types.
Outcomes of Hip Arthroscopy in Patients With Acetabular Cysts: A Multicenter Matched Controlled Study From the MASH Study Group
Matsuda, Dean, Wolff, Andrew B. , Nho, Shane, Christoforetti, John J. , Salvo, John P. , Martin, RobRoy L., McGovern, Ryan P. , Silk, Richard J., Ishimoto, Allysa, Ko, Brandon, Matsuda, Dean K. , Martin, RobRoy L. , Carreira, Dominic S.

Mayo Clinic

The American Journal of Sports Medicine | January 21, 2026 | Volume: 54 | Issue: 2 | Pages: 424-430

10.1177/03635465251405731 | PMID 41562523 Get It

Background: Some studies have reported more severe chondral pathology and less successful hip arthroscopic outcomes in patients with acetabular subchondral cysts. Purpose/Hypothesis: The purpose of this study was to report multicenter arthroscopic outcomes of patients with and without acetabular bone cysts. It was hypothesized that patients with acetabular cysts would demonstrate inferior outcomes at minimum 2-year follow-up compared with patients without acetabular cysts. Study Design: Cohort study; Level of evidence, 3. Methods: A multicenter matched-pair study was performed across 6 medical centers with data from a large prospectively collected database. Inclusion criteria were adult patients who had undergone primary unilateral hip arthroscopy for femoroacetabular impingement syndrome (FAIS). The study group was defined by the presence of a superolateral acetabular subchondral cyst on preoperative imaging. A control group was matched on age; sex; body mass index (BMI); lateral center-edge angle (LCEA); alpha angle; arthroscopic treatments of femoroplasty, acetabuloplasty, and labral treatment (ie, repair, reconstruction, or debridement); Beck chondral grade; and minimum 2-year outcomes using visual analog scale (VAS) for pain, International Hip Outcome Tool-12 (iHOT-12), minimal clinically important difference (MCID), substantial clinical benefit (SCB), and Patient Acceptable Symptom State (PASS). Results: The study included 82 patients, of whom 41 composed the study group and 41 served as matched control patients. The study group had a mean age of 42.16 ± 11.26 years with 48.78% women and a mean BMI of 26.51 ± 4.31 kg/m 2 . Mean LCEA was 33.55°± 6.30°, and mean alpha angle was 70.22°± 9.71°. Mean Beck chondral grade was 2.59 ± 1.27 in the study group and 2.70 ± 0.95 in the matched control group ( P = .72). Two-year mean postoperative iHOT-12 scores for the study and control groups were 69.49 ± 24.51 and 73.24 ± 25.16, respectively ( P = .38), whereas mean postoperative VAS scores for pain were 18.84 ± 18.17 and 20.74 ± 21.39, respectively ( P = .70). The study group reached MCID in 82.93%, SCB in 58.54%, and PASS in 65.85% and were similar to those of the control group. Conclusion: Patients undergoing arthroscopic surgery for FAIS with acetabular cysts had similarly successful outcomes as patients without acetabular cysts. Acetabular subchondral cysts may not be a contraindication to hip arthroscopy in patients with FAIS who would otherwise be indicated for this surgery.
EP133 Short Term Outcomes of Hip Arthroscopy Patients with Acetabular Subchondral Cysts: This Changes Things
Matsuda, Dean, Nho, Shane, Wolff, Andrew, Christoforetti, John J. , Salvo, John P. , Silk, Jake, Martin, RobRoy, McGovern, Ryan P. , Ko, Brandon, Ishimoto, Alyssa, Matsuda, Dean K. , Nho, Shane J. , Carreira, Dominic S.

Mayo Clinic

Journal of Hip Preservation Surgery | December 22, 2025 | Volume: 12 | Issue: Supplement_2 | Pages: ii82-ii82

10.1093/jhps/hnaf069.261 Get It

Abstract Background Some studies have reported more severe chondral pathology and less successful hip arthroscopic outcomes in patients with acetabular subchondral cysts. Purpose The purpose of this study is to report multicenter arthroscopic outcomes of patients with and without acetabular bone cysts. Methods A multicenter matched-pair study was performed with data from a large prospectively collected database. Inclusion criteria were adult patients that had undergone primary unilateral hip arthroscopy for femoroacetabular impingement syndrome (FAIS). The study group was defined by the presence of a superolateral acetabular subchondral cyst on preoperative imaging with &gt; 2mm minimum joint width. 1:1 matching on age, gender, Body Mass Index (BMI), lateral center-edge angle (LCEA), Alpha angle, and rendered arthroscopic treatments of femoroplasty, acetabuloplasty, and labral treatment (i.e., repair, reconstruction, or debridement). Beck chondral grade and minimum 2-year outcomes utilizing VAS for pain, iHOT-12, MCID, SBC, and PASS scores were compared. Results There were 82 patients. The study group had a mean age of 42.16 ± 11.26 years with 48.78% women and a mean BMI of 26.51 ± 4.31 kg/m2. Mean Beck chondral grade was 2.59 ± 1.27 in the study group and 2.70 ± 0.95 in the matched control group (p=0.72). Two-year mean postoperative iHOT-12 scores for the study and control groups were 69.49 ± 24.51 and 73.24 ± 25.16 (p=0.38), while mean postoperative pain VAS were 18.84 ± 18.17 and 20.74 ± 21.39 (p=0.70) The study group reached MCID in 82.93%, SBC in 58.54%, and PASS in 65.85%. The control group reached MCID in 78.05%, SBC in 65.85%, and PASS in 73.17%, with no significant difference between the cohorts (p=0.57, p=0.49, p=0.47, respectively). Discussion/Conclusion Acetabular subchondral cysts are not associated with more chondral pathology than strictly matched controls and may not be a contraindication to hip arthroscopy in patients with FAIS that would otherwise be indicated for this surgery. This finding has pragmatic value in that a significant subset of patients that would otherwise have been denied elective hip arthroscopy may now be potential arthroscopic candidates.
Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation
Ahmed, Raheel , Jamil, Yumna , Ramphul, Kamleshun , Mactaggart, Sebastian , Bilal, Maham , Shi, Rui , Azzu, Alessia , Memon, Rahat A , Sakthivel, Hemamalini, Khattar, Rajdeep , Wells, Athol U. , Baksi, John Arun, Wechalekar, Kshama , Sharma, Rakesh, Ahmed, Raheel , Dulay, Mansimran Singh , Okafor, Joseph , Kouranos, Vasileios , Chahal, C. Anwar A.

Mayo Clinic

Pacing and Clinical Electrophysiology | July 30, 2024 | Volume: 47 | Issue: 10 | Pages: 1394-1403

10.1111/pace.15051 | PMID 39078380 Get It

AbstractIntroductionIn patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation.MethodsThe 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs.ResultsAmong 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p < .01), had higher rates of diabetes (31.7% vs. 21.6%, p < .01) and chronic kidney disease (CKD) (16.8% vs. 7.8%, p < .01) but lower prevalence of atrial fibrillation (AF) (11.9% vs. 23.5%, p < .01), sick sinus syndrome (4.0% vs. 7.8%, p = .024), ventricular fibrillation (VF) (9.9% vs. 15.7%, p = .02), and black ancestry (31.9% vs. 58.0%, p < .01). Unadjusted major adverse cardiovascular events (MACE), defined as a composite of in‐hospital death, myocardial infarction (MI), and ischemic stroke, was higher in females (11.8% vs. 6.9%, p = .024), but when adjusted for age and tCharlson Comorbidity Index (CCI), females demonstrated significantly lower odds of experiencing MACE (aOR: 0.048, 95% CI: 0.006–0.395, p = .005). Incidence of acute kidney injury (AKI) post‐ICD was significantly lower in females (15.7% vs. 23.8%, p = .01) as was the adjusted odds (aOR: 0.282, 95% CI: 0.146–0.546, p < .01). There was comparable mean length of stay and hospital charges.ConclusionICD utilization in CS patients is more common among males, who have a higher prevalence of diabetes and CKD but a lower prevalence of AF, sick sinus syndrome, and VF. Adjusted MACE and AKI were significantly lower in females.
Management of cardiac sarcoidosis
Sharma, Rakesh , Metra, Marco , Heidecker, Bettina , Baksi, John, Wicks, Eleanor , Tschöpe, Carsten , Petersen, Steffen E. , Lüscher, Thomas F. , Filippatos, Gerasimos , Metra, Marco , Klingel, Karin , Imazio, Massimo , Petersen, Steffen E , Heidecker, Bettina , Tschöpe, Carsten , Sharma, Rakesh , Kouranos, Vasileios , Cooper, Leslie T. , Ristić, Arsen , Merino, José Luís , Imazio, Massimo , Chillou, Christian de , Kuchynka, Petr , McDonagh, Theresa A.

Mayo Clinic

European Heart Journal | May 22, 2024 | Volume: 45 | Issue: 30 | Pages: 2697-2726

10.1093/eurheartj/ehae356 | PMID 38923509 Get It

Abstract Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with significant clinical complications such as high-degree atrioventricular block, ventricular tachycardia, and heart failure as well as sudden cardiac death. It is therefore important to provide an expert consensus statement summarizing the role of different available diagnostic tools and emphasizing the importance of a multidisciplinary approach. By integrating clinical information and the results of diagnostic tests, an accurate, validated, and timely diagnosis can be made, while alternative diagnoses can be reasonably excluded. This clinical expert consensus statement reviews the evidence on the management of different CS manifestations and provides advice to practicing clinicians in the field on the role of immunosuppression and the treatment of cardiac complications based on limited published data and the experience of international CS experts. The monitoring and risk stratification of patients with CS is also covered, while controversies and future research needs are explored.
RANDOMIZED TRIAL COMPARING MICROSERRATED VERSUS CONVENTIONAL INTERNAL LIMITING MEMBRANE FORCEPS FOR INTERNAL LIMITING MEMBRANE PEELING
Hinkle, John C. , Patel, Luv, Ammar, Michael J., Soares, Rebecca R. , Cohen, Michael N. , Hsu, Jason , Yonekawa, Yoshihiro , Regillo, Carl D. , Gupta, Omesh P. , Starr, Matthew R , Starr, Matthew R. , PATEL, SAMIR N. , Ho, Allen C.

Mayo Clinic

Retina | April 29, 2024 | Volume: 44 | Issue: 8 | Pages: 1323-1328

10.1097/iae.0000000000004138 | PMID 39047125 Get It

Purpose: To evaluate anatomic outcomes and surgeon response following the use of microserrated (Sharkskin, Alcon, Forth Worth, TX) internal limiting membrane (ILM) forceps compared with conventional (Grieshaber; Alcon) ILM forceps for peeling of the ILM. Methods: Patients were prospectively assigned in a 1:1 randomized fashion to undergo ILM peeling using microserrated forceps or conventional forceps. Rates of retinal hemorrhages, deep retinal grasps, ILM regrasping, time to ILM removal, and surgeon questionnaire comparing the use of microserrated and conventional ILM forceps were analyzed. Results: A total of 90 eyes of 90 patients were included in this study. The mean number of deep retinal grasps was higher in the conventional forceps group (1.51 ± 1.70 vs. 0.33 ± 0.56, respectively [P < 0.0001]). The mean number of failed ILM grasps was higher with conventional forceps (6.62 ± 3.51 vs. 5.18 ± 2.06 [P = 0.019]). Microserrated forceps provided more comfortability (lower number) in initiating the ILM flap (2.16 ± 0.85 vs. 1.56 ± 0.76, P < 0.001), comfortability in regrasping the ILM flap (2.51 ± 1.01 vs. 1.98 ± 0.89, P = 0.01), and comfortability in completing the ILM flap (2.42 ± 1.03 vs. 1.84 ± 1.02, P = 0.01). Conclusion: Surgeons utilizing the microserrated forceps experienced fewer deep retina grasps and fewer failed ILM grasps compared with conventional ILM forceps. The microserrated forceps was also a more favorable experience subjectively among the surgeons.